EpiSante Biomedical | Establishment and Consulting of LDTs Lab | DNA methylation analysis | cancer management

There are many tumor suppressor genes within cells that are responsible for inhibiting the formation of cancer. When tumor suppressor genes are excessively methylated, it causes these genes to be unexpressed, leading to cell carcinogenesis. Abnormal DNA methylation occurs at a very early stage of cancer, making methylation markers very suitable as tools for cancer screening.

LiverMeth liver cancer gene methylation test uses liquid biopsy methylation detection technology to detect the methylation levels of tumor suppressor genes highly related to liver cancer, assessing the risk of liver cancer. It has better detection sensitivity than traditional liver cancer serum markers and can be combined with liver cancer indicators for evaluation and judgment.